Literature DB >> 1447122

IL-1 receptor antagonist release is regulated differently in human alveolar macrophages than in monocytes.

J N Kline1, M M Monick, G W Hunninghake.   

Abstract

These studies compared the release of interleukin-1 receptor antagonist (IL-1 RA) from alveolar macrophages and peripheral blood monocytes. The cells were cultured in medium containing various amounts of heat-inactivated fetal calf serum (FCS), granulocyte-macrophage colony-stimulating factor (GM-CSF), lipopolysaccharide (LPS), and immunoglobulin G (IgG). In serum-free medium alone, IL-1 RA release was similar from macrophages and monocytes. Increasing FCS concentration caused a significant upregulation of IL-1 RA release in macrophages but not in monocytes. GM-CSF caused a small increase in both cell types. LPS caused downregulation of IL-1 RA release from monocytes but not from macrophages. IgG did not affect IL-1 RA release in either cell group. These studies demonstrate that regulation of IL-1 RA release is different in monocytes and macrophages.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1447122     DOI: 10.1152/jappl.1992.73.4.1686

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  3 in total

Review 1.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

2.  Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB).

Authors:  J Kadota; Y Matsubara; Y Ishimatsu; M Ashida; K Abe; R Shirai; K Iida; K Kawakami; H Taniguchi; T Fujii; M Kaseda; S Kawamoto; S Kohno
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

3.  Regulatory effects of endogenous interleukin-1 receptor antagonist protein in immunoglobulin G immune complex-induced lung injury.

Authors:  T P Shanley; J L Peters; M L Jones; S W Chensue; S L Kunkel; P A Ward
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.